(Total Views: 462)
Posted On: 12/07/2022 3:13:15 PM
Post# of 155812
Jeff wrote:
Except that a CEO would have insider information. And even if you don't have insider information, all you have to do is read some of the FDA comments on the job that Amarex didn't do and you wouldn't imagine the case is a hurdle rather than an opportunity to recoup some of the massive amount of cash lost as a result of Amarex's either inexplicable or darkly explicable blunders.
Quote:
Anything can happen in a trial so it’s a hurdle unless we have insider information on how the negotiations are going or know one of the lawyers involved in the case. That’s how a CEO would look at this situation if it was their company involved with AMAREX.
Except that a CEO would have insider information. And even if you don't have insider information, all you have to do is read some of the FDA comments on the job that Amarex didn't do and you wouldn't imagine the case is a hurdle rather than an opportunity to recoup some of the massive amount of cash lost as a result of Amarex's either inexplicable or darkly explicable blunders.
(2)
(0)
